Literature DB >> 9114721

Low grade adenocarcinoma simulating benign glandular lesions in needle prostatic biopsy.

J Arista-Nasr1, E Cortés, R Pichardo.   

Abstract

In order to define the frequency and morphological characteristics of low grade adenocarcinomas misdiagnosed as benign prostatic hyperplasia in needle prostatic biopsies, we reviewed 135 consecutive needle biopsies with prostatic cancer. In three biopsies (2.2%) low grade adenocarcinoma was found as a single neoplastic pattern simulating benign hyperplastic gland in some histological fields and prostatic adenosis in others. These biopsies showed the histological features described for carcinomas originating in the transition zone and were seen in isolated histological fields. Retrospectively, it was found that these biopsies showed features of adenocarcinoma although some histologic criteria of malignancy such as infiltrative pattern, prominent nucleoli and nuclear enlargement were seen only focally. Blue mucinous secretions, crystalloids, occasional stromal single cells and mitotic figures were absent. We conclude that a detailed analysis of architectural and cytological features must be made of all glandular proliferations, since this type of low grade adenocarcinoma can occasionally be found in needle prostatic biopsies as the only neoplastic pattern in needle biopsy specimens and simulate benign glandular lesions.

Entities:  

Mesh:

Year:  1997        PMID: 9114721

Source DB:  PubMed          Journal:  Rev Invest Clin        ISSN: 0034-8376            Impact factor:   1.451


  2 in total

1.  Proliferative lesions of prostate: a multivariate approach to differential diagnosis.

Authors:  Fernanda de Barros Correia Cavalcanti; Venâncio Avancini Ferreira Alves; Julio Pereira; Cristina T Kanamura; Alda Wakamatsu; Luís Balthazar Saldanha
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

2.  Pseudohyperplastic prostatic adenocarcinoma in transurethral resections of the prostate.

Authors:  Julián Arista-Nasr; Braulio Martinez-Benitez; Samuel Valdes; Mercedes Hernández; Leticia Bornstein-Quevedo
Journal:  Pathol Oncol Res       Date:  2003-12-22       Impact factor: 3.201

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.